LIFEMD INCLFMD
ASignal's systematic analysis rates LFMD as Neutral.
Reflects the latest available analysis · analyzed Oct 19, 2026
The case on LFMD
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Oversold RSI at 18.18 indicating potential reversal
- High gross margin of 87.50% suggests pricing power
- Significant cash reserves with $25.14M in total cash
- Low forward P/E of 5.92x suggesting potential undervaluation
- Strong downtrend with price below SMA20 and SMA50
- Negative MACD histogram indicating weakening momentum
- Negative operating and free cash flow
- Negative return on equity (-515.90%) and return on assets (-18.92%)
- Declining revenue growth (YoY: -3.50%)
- High debt-to-equity ratio of 0.76x with deteriorating financial health
See the full verdict on LFMD
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes LFMD
Most investors never get a second opinion, let alone several. ASignal runs LFMD past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.